Pemetrexed ditromethamine Hospira (pemetrexed)
Generic
- Region
- 🇪🇺 EU
- Active substance
- pemetrexed
- Status
- Application withdrawn
- Therapeutic area
- Mesothelioma; Carcinoma, Non-Small-Cell Lung
- Designations
- Generic
- Application
- EMEA/H/C/004306
- ATC
- L01BA04
- Official record
- www.ema.europa.eu
Indication
Treatment of malignant pleural mesothelioma and non-small cell lung cancer
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Pemetrexed medac Withdrawn · medac Gesellschaft für klinische Spezialpräparate mbH
- 🇪🇺 Pemetrexed Baxter Withdrawn · Baxter Holding B.V.
- 🇪🇺 Alimta Authorised · Eli Lilly Nederland B.V.
- 🇪🇺 Pemetrexed Accord Authorised · Accord Healthcare S.L.U.
- 🇪🇺 Pemetrexed Pfizer (previously Pemetrexed Hospira) Authorised · Pfizer Europe MA EEIG
- 🇪🇺 Armisarte (previously Pemetrexed Actavis) Authorised · Actavis Group PTC ehf
- 🇪🇺 Pemetrexed Fresenius Kabi Authorised · Fresenius Kabi Deutschland GmbH
- 🇪🇺 Pemetrexed Sandoz Withdrawn · Sandoz GmbH
- 🇪🇺 Ciambra Withdrawn · Menarini International Operations Luxembourg S.A.
- 🇪🇺 Pemetrexed Krka Withdrawn · KRKA tovarna zdravil d.d. Novo mesto
- 🇪🇺 Pemetrexed Lilly Withdrawn · Eli Lilly Netherlands
- 🇪🇺 Pemetrexed Pfizer (previously Pemetrexed Hospira UK Limited) Withdrawn · Pfizer Europe MA EEIG
Follow Pemetrexed ditromethamine Hospira
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.